A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD)
A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD)
Recruiting · NCT06389877 · Registry updated 2026-10-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Subcutaneous Emphysema, alpha 1-antitrypsin deficiency, hereditary disease, liver disorder, lung disorder, pulmonary emphysema, respiratory system disorder | Recruiting | Phase 1 / Phase 2 | 2026-10-05 | NCT06389877 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Beam Therapeutics Inc. | 8 |
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Clinical Study Center | Leiden | Netherlands | 2 |
| Clinical Study Center | London | United Kingdom | 6 |
| Clinical Study Center | Adelaide | Australia | 3 |
| Clinical Study Center | Birmingham | United States | 1 |
| Clinical Study Center | Auckland | New Zealand | 3 |
| Clinical Study Center | Hamilton | New Zealand | 1 |
| Clinical Study Center | Southampton | United Kingdom | 2 |
| Clinical Study Center | Boston | United States | 2 |
| Clinical Study Center | Birmingham | United Kingdom | 2 |
| Clinical Study Center | Dublin | Ireland | 1 |
| Clinical Study Center | Fitzroy | Australia | 1 |
| Clinical Study Center | Charleston | United States | 2 |